A NEW drug to tackle Alzheimer's has been approved in the US amid growing calls for the NHS to improve early diagnosis so Brits can benefit from the treatment.
UK regulators are still considering donanemab but could follow the US Food and Drug Administration which on Tuesday approved what is one of the world's first disease-modifying treatments for dementia.
Bu hikaye Daily Mirror UK dergisinin July 04, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Daily Mirror UK dergisinin July 04, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
NORTHERN LIGHTS
O'Neill's wonder boys ready to shine on world stage says Shea
KNOCKED FOR SIX
Emotional Rory equals Seve record and admits: I've been through a lot so to finish '24 like this is a dream,
GREAT BRITISH BRAKE OFF
Emma and Katie too hot for champions Canada
GAT TO HURT
A record 11th consecutive defeat for Wales and coach Warren has no idea on future
WE BELIEVE IN STEVE
Itoje and Steward jump to defence of Borthwick after England suffer a fifth successive loss
TROLLS POSTING FAKE LIAM FUNERAL VIDEOS
Bogus clips flooding TikTok
Jude's defender
England ace hirés minder
ONE SHOW'S LAUREN GETS BACK TO WORK
Presenter, 46, returns to BBC after her cancer diagnosis
Biden OKs Ukraine long-range strikes
US missiles can hit targets in Russia
TRUMP'S LOST HIS SPARKLER
He misses out in bid to buy £1.6m orange diamond
